A 6-year-old child from rural India presents with a 3-month history of low-grade fever, weight loss, and persistent cough. Chest X-ray shows a right hilar lymphadenopathy with no parenchymal consolidation. Mantoux test is 18 mm. Sputum smear microscopy is negative for acid-fast bacilli. What is the most appropriate next step in management?

Explanation

## Clinical Diagnosis of Pediatric TB **Key Point:** In children with suspected tuberculosis, bacteriological confirmation is often not possible because children are typically sputum-smear negative (paucibacillary disease). Diagnosis relies on clinical, radiological, and immunological evidence. ### Diagnostic Approach in This Case The child presents with: - Prolonged constitutional symptoms (fever, weight loss, cough × 3 months) - Radiological finding consistent with TB (hilar lymphadenopathy) - Positive Mantoux test (≥15 mm in an unvaccinated or BCG-vaccinated child with symptoms is significant) - Negative sputum smear (expected in pediatric TB) **High-Yield:** Pediatric TB is predominantly **lymph node disease** (especially hilar and mediastinal), not cavitary pulmonary disease. Sputum smear negativity does NOT exclude TB in children. ### Why Start ATT Now? 1. **Clinical suspicion is high** — constitutional symptoms + epidemiological risk + radiological findings 2. **Mantoux positivity** supports active TB 3. **Delay risks disease progression** — TB in children progresses rapidly to severe forms (miliary, meningeal) 4. **WHO/IAP guidelines** recommend starting ATT in children with strong clinical suspicion, even without bacteriological confirmation 5. **Sputum smear negativity is expected** — do not wait for culture results (which take 2–8 weeks) **Clinical Pearl:** The diagnosis of TB in children is often made on the basis of **clinical judgment** (Crofton score or similar scoring systems) combined with radiological evidence and TST/IGRA positivity, NOT bacteriological proof. ### Standard Pediatric ATT Regimen | Phase | Duration | Drugs | Dosing (mg/kg/day) | |-------|----------|-------|--------------------| | **Intensive** | 2 months | HRZE | H: 10, R: 15, Z: 25, E: 25 | | **Continuation** | 4 months | HR | H: 10, R: 15 | **Total duration:** 6 months for drug-susceptible pulmonary TB ## Why Other Options Are Incorrect **Option 1 (Repeat sputum smear in 2 weeks):** Delays diagnosis and treatment; sputum smear is unreliable in pediatric TB and a negative result does not exclude disease. **Option 2 (CT chest to rule out malignancy):** Unnecessary and delays treatment. The clinical picture is classic for TB, not malignancy. Imaging should not be used to exclude TB. **Option 3 (Bronchoscopy with BAL):** Invasive and not indicated as a first step. BAL culture has low sensitivity in pediatric TB and is reserved for diagnostic uncertainty or suspected drug-resistant TB in specialized centers. **Mnemonic:** **CHIME** — Clinical suspicion, Hilar lymphadenopathy, Immunological evidence (Mantoux), Months of symptoms, Epidemiological risk = Start ATT.